SC Johnson Wins WHO Backing for New Tool to Prevent Malaria and Other Insect-Borne Diseases

SC Johnson Guardian™

By Staff Reporter  NAIROBI, KENYA, August 15, 2025 – Today, the World Health Organization (WHO) announced a policy recommendation for spatial repellents to be used as an innovative tool to help fight insect-borne diseases like malaria. SC Johnson, maker of household brands such as OFF!®, Baygon® and Raid® and leaders in insect science, has been working towards this achievement for more than a decade and has already been distributing millions of its own company-developed and manufactured spatial repellents – SC Johnson Guardian™ and SC Johnson Mosquito Shield™ – to communities…

Read More

Zimbabwe Launches Unitaid-Funded Project to Tackle Drug-Resistant TB Through Community Power

By Michael Gwarisa  Zimbabwe has taken a bold step in the fight against drug-resistant tuberculosis (DR-TB) with the launch of the Unitaid-funded COMBAT DRTB project, an ambitious initiative set to place communities at the center of TB care and drive transformative change in how the disease is managed across the country. The project, officially titled Community-Driven Approaches for Transformative Change to Combat Drug-Resistant TB (COMBAT DRTB), was unveiled today at an inception meeting held in Harare, bringing together stakeholders from government, civil society, academia, and development partners. The launch marks…

Read More

Africa CDC and Unitaid partner to strengthen equitable access to health products in Africa

By Staff Reporter The Africa Centres for Disease Control and Prevention (Africa CDC) and Unitaid have formed a new strategic partnership to expand the production of essential health products in Africa and improve sustainable access to medicines, diagnostics, and medical oxygen across the continent. Signed on the margins of the 78th World Health Assembly, the Memorandum of Understanding focuses on scaling up regional manufacturing as a central pillar of Africa’s health security and autonomy. Africa bears 25% of the global disease burden yet imports more than 95% of the active pharmaceutical…

Read More